Marshall Sack
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies 3
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 4
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
- Hepatology top 10%
- Nephrology top 10%
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 4
- Pharmacogenetics and Drug Metabolism 3
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Peroxisome Proliferator-Activated Receptors 2
-
- Toxin Mechanisms and Immunotoxins 1
-
- Cancer, Lipids, and Metabolism 1
-
- Pneumonia and Respiratory Infections 1
- Co-authors
- Roy D. AltmanRobert A. BlumMartin I. FreedAnn K. MillerSuzanne K. SwanThomas MarburySamir K. GuptaVijay Batra
- Cited by
- RheumatologyPharmacologyHepatology
- Journals
- The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomNew Zealand
In The Last Decade
Marshall Sack
12 papers receiving 473 citations
Peers
Comparison fields: 5 of 79
- Rheumatology 153
- Pharmacology 122
- Hepatology 56
- Nephrology 41
- Pharmacology 46
Countries citing papers authored by Marshall Sack
This map shows the geographic impact of Marshall Sack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall Sack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall Sack more than expected).
Fields of papers citing papers by Marshall Sack
This network shows the impact of papers produced by Marshall Sack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall Sack. The network helps show where Marshall Sack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marshall Sack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 32 | |
| 2 | 2003 | 32 | |
| 3 | 2003 | 68 | |
| 4 | 2002 | 61 | |
| 5 | 2001 | 26 | |
| 6 | Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis. | 2000 | 33 |
| 7 | 1999 | 63 | |
| 8 | 1999 | 10 | |
| 9 | 1996 | 20 | |
| 10 | 1995 | 24 | |
| 11 | 1994 | 81 | |
| 12 | Prognostic factors in polyarteritis. | 1975 | 67 |
About Marshall Sack
Marshall Sack is a scholar working on Pharmacology, Pharmacology and Rheumatology, having authored 12 papers that have together received 517 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Toxin Mechanisms and Immunotoxins (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Rheumatology (153 citations), Pharmacology (122 citations) and Hepatology (56 citations). Marshall Sack has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Roy D. Altman, Robert A. Blum, Martin I. Freed, Ann K. Miller, Suzanne K. Swan, Thomas Marbury, Samir K. Gupta, Vijay Batra, Paul Glue and Melton B. Affrime. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Clinical Therapeutics, Seminars in Arthritis and Rheumatism and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.